Impact of real-time notification of Clostridium difficile test results and early initiation of effective antimicrobial therapy

Am J Infect Control. 2018 May;46(5):538-541. doi: 10.1016/j.ajic.2017.11.010. Epub 2018 Jan 3.

Abstract

Background: Clostridium difficile is a prominent nosocomial pathogen and is the most common causative organism of health care-associated diarrhea. To our knowledge, no studies have investigated the impact of real-time notification of culture results with rapid antimicrobial stewardship program (ASP) intervention in the setting of C difficile infection (CDI). The purpose of this study was to assess the impact of real-time notification of detection of toxigenic C difficile by DNA amplification results in patients with confirmed CDI.

Methods: This is a single-center, retrospective cohort study at a 433-bed tertiary medical center in central Kentucky. The study consisted of 2 arms: patients treated for CDI prior to implementation of real-time provider notification and patients postimplementation. The primary outcome was time to initiation of effective antimicrobial therapy.

Results: The median time to initiation of effective antimicrobial therapy decreased from 5.75 hours in the preimplementation cohort to 2.05 hours in the postimplementation cohort (P = .001). ASP intervention also resulted in a shorter time from detection of CDI to order entry of effective antimicrobial therapy in the patient's electronic medical record (3.0 vs 0.6 hours; P = .001).

Conclusions: The implementation of a real-time notification system to alert a pharmacist-led ASP of toxigenic CDI resulted in statistically significant shorter times to order entry and subsequent initiation of effective antimicrobial therapy and contact precautions.

Keywords: Clostridium difficile; antimicrobial stewardship program; early initiation; infection prevention; time to effective therapy.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use*
  • Antimicrobial Stewardship / organization & administration*
  • Clostridioides difficile / isolation & purification*
  • Clostridium Infections / diagnosis*
  • Clostridium Infections / drug therapy*
  • Cross Infection / diagnosis*
  • Cross Infection / drug therapy*
  • Early Diagnosis
  • Female
  • Health Services Research
  • Humans
  • Kentucky
  • Male
  • Middle Aged
  • Molecular Diagnostic Techniques
  • Retrospective Studies
  • Secondary Prevention
  • Tertiary Care Centers
  • Time Factors

Substances

  • Anti-Bacterial Agents